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Introduction
We have previously shown that the Cardiotonic Steroid (CTS), 
Marinobufagenin (MBG), plays an important role in the pathogenesis 
of experimental uremic cardiomyopathy induced by partial (i.e., 5/6th) 
nephrectomy (PNx) in the rat [1]. Specifically, we have demonstrated 
that infusion of MBG via an osmotic minipump to achieve similar 
elevations in plasma MBG concentration as that seen with PNx, produces 
a very similar cardiac phenotype. Moreover, we have also shown that 
both active and passive immunization against MBG both prevents and 
reverses phenotypic changes induced by PNx i.e., cardiac hypertrophy, 
diastolic dysfunction and cardiac fibrosis [2,3]. Additionally, we have 
observed that the putative aldosterone antagonists, spironolactone 
and its major metabolite, canrenone, prevent binding of radiolabeled 
ouabain to Na/K-ATPase in a competitive manner, additionally these 
compounds also prevented MBG-induced increases in fibroblast 
collagen production  [4]. In the same report we also demonstrated 
that administration of spironolactone through osmotic minipump 
attenuates development of experimental uremic cardiomyopathy.
Indications are that men possess a greater risk for cardiovascular 
and renal disease than age-matched, premenopausal women [5]. The 
National Health and Nutrition Evaluation Survey (NHANES III) also 
showed that, in general, men had higher blood pressure than women 
through middle age [6]. Progesterone, a major female sex hormone, 
was found to affect salt-sensitive hypertension in women [7]. Due to 
structural similarity, progesterone was reported to compete with CTS 
binding to Na/K-ATPase, an important Na+ and K+ ion transporter 
found on the plasma membrane of all mammalian cells [8]. The 
current study evaluates whether the competitive effects of progesterone 
ameliorate cardiovascular change in an experimental setting in which 
MBG concentration is increased, viz., PNx operated rats.
Methods
Animals
Male and Female Sprague-Dawley rats were used for surgical 
studies. All of the experiments presented in this manuscript were 
conducted in accordance with the National Institutes of Health, Guide 
for the Care and Use of Laboratory Animals, using protocols approved 
by the University of Toledo, Health Science Campus, Institutional 
Animal Care and Use Committee.
Experimental groups
Male rats weighing 250 g to 300 g and female rats weighing 150 g 
to 200 g were divided into 4 groups with 6-12 rats surviving surgical 
manipulation in each group. Group 1 (male) and Group 2 (female) 
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were sham-operated controls whereas Group 3 (male) and Group 4 
(female) received PNx surgery as previously described [3].
Blood pressure and progesterone measurement
Conscious Blood pressure (BP) was measured by the tail cuff 
method immediately prior to and once a week for three consecutive 
weeks following surgery. Blood pressure measurements were taken 
using equipment from IITC, Inc. (Amplifier model 229, Monitor 
Model 31, Test chamber model 306, IITC Life Science, Woodland 
Hills, CA), as previously described [3]. Four weeks following surgery 
animals were euthanized. At that time their body and heart weights 
were recorded and blood was collected in heparinized tubes for plasma 
preparation. Left ventricle tissue of these animals was halved and fixed 
in 4% formaldehyde overnight before processing for histology. For 
progesterone measurement, plasma samples were first diluted 10 times 
and progesterone concentrations were measured using an Enzyme 
immunoassay kit from Cayman Chemical (Ann Arbor, MI) following 
the manufacturer’s protocol.
Isolation of cardiac fibroblasts
Isolation of cardiac fibroblasts was carried out as described 
previously by Brilla and Rupp [9], with modifications [10]. Briefly, 
hearts of adult male Sprague-Dawley rats weighing between 250-300 
g, were used to obtain fibroblasts. The rats were anesthetized with 
pentobarbital (50mg/kg), and their hearts then removed and perfused 
under sterile conditions via the ascending aorta with Joklik’s medium 
(Sigma-Aldrich, St. Louis, MO) on a modified Langendorff Apparatus. 
After 5 min of perfusion, perfusate was switched to Joklik’s medium 
containing 0.1% Collagenase type 2 (Worthington Biochemical, 
Lakewood, NJ) and 0.1% bovine serum albumin (BSA) which was 
circulated for 15-25 min or until the heart became flaccid. After 
perfusion the heart was removed from the apparatus and the ventricles 
were excised, finely cut, and shaken in Joklik’s modified medium with 
0.1% Collagenase and 0.1% BSA for 15 min. The resulting cell/tissue 
suspension was allowed to settle for 15 min and was centrifuged at 500 
rpm for 10 min. The supernatant was then centrifuged at 1500 rpm 
for 15 min. The resulting Pellet was suspended in Dulbecco’s Modified 
Eagle Medium (DMEM, Sigma-Aldrich) supplemented with antibiotics 
(penicillin/streptomycin/fungizone) and 15% fetal bovine serum 
(FBS, Hyclone, Logan, UT). The resulting resuspended pellet, which 
contained Cardiac fibroblasts, was seeded onto plates and incubated 
for 1 h. Unattached cells were removed by changing the media and any 
remaining attached fibroblast cells were allowed to grow to confluence. 
Subsequently they were trypsinized and passaged once at 1:3 dilution. 
Cells were then allowed to grow to confluence before being utilized for 
experiments.
(3H) Ouabain binding studies
Ouabain binding studies were performed using purified Na/K-
ATPase from porcine renal proximal tubules and 3H-labeled ouabain 
as described previously [4]. Purified Na/K-ATPase was incubated with 
or without progesterone for 30 min in a K+-free Kreb’s solution at 37°C, 
followed by adding varying amounts of 3H-ouabain. After another 30 
min of incubation at the same temperature, the entirety of the solution 
was transferred onto a 0.2 µm membrane and washed three times with 
ice-cold K+-free Kreb’s solution. After being washed the membrane was 
then transferred to a scintillation vial for measurement of radioactivity. 
The dissociation constant (Kd) value of 3H-ouabain was calculated 
using one binding site curve fitting.
Western blot analysis
Cardiac fibroblasts were grown in DMEM with 15% FBS to 
confluence and then starved by changing the medium to DMEM 
containing 1% FBS for an additional 24 h. The starved cells were then 
treated with varying concentrations of MBG, Progesterone or both 
for 24 h. Subsequently, treated cells were washed twice with ice cold 
Phosphate Buffered Saline (PBS), and exposed to RIPA lysis buffer 
from Santa Cruz Biotechnology (Santa Cruz, CA). Gel Electrophoresis 
for western blotting was carried out using precast Ready Gels 4-15% 
Tris-HCl, purchased from Bio-Rad (Hercules, CA). The proteins from 
the gel were electro-transferred to a nitrocellulose membrane. The 
membrane was blocked with 5% nonfat dry milk in 20 mM Tris-HCl 
(pH 7.5, 150 mM CaCl2, and 0.1% Tween-20). Goat anti-type 1 collagen 
antibody (Southern Biotech, Birmingham, AL) was used to probe for 
procollagen-1. Secondary anti-goat horse radish peroxidase conjugated 
antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, 
CA). The structural protein β-actin was used as loading control.
Histology
Sirius Red/Fast green staining for collagen was performed on left 
ventricular tissues and fibrosis quantified using a protocol modeled 
after Junquiera et al. [11] and Puchtler et al. [12]. Briefly, 4 µm sections 
of paraffin embedded left ventricular sections were mounted on slides 
and subsequently deparaffinized by incubation in Xylene overnight, the 
tissue sections were then re-hydrated by sequential 3min incubations 
in: 100% Ethanol (EtOH, 3X), 95% EtOH (1X), and 80% EtOH (1X). 
Slides were then incubated in Sirius red solution (0.25 g, Direct Red 
80, Sigma; 250 mL, saturated aqueous picric Acid, RICCA Chemical, 
Arlington, TX; and 250 µL, of Picric acid reagent plus, Sigma) for 1 h. 
The slides were then washed in 3 changes of acidified water (0.005% 
acetic acid solution), then incubated in Fast Green dying solution (0.25 
g, Fast green FCF, Sigma; 250 mL, saturated aqueous solution of picric 
acid; 250 µL, of picric acid reagent plus) for 1 h. Slides were then washed 
again in 3 changes of acidified water, dehydrated in 3 changes of 100% 
EtOH, cleared in Xylene and mounted with a resinous medium. Bright 
field images of the stained slides were taken at 20X on an Olympus 
FSX100 system and analyzed for collagen by ImageJ (NIH).
Statistical analysis
Data presented are the mean ± standard error of the mean. Data 
obtained were first tested for normality. Based on whether the data 
were normal either an ANOVA followed by Tukey’s post-hoc test 
comparing means of all groups (if normal), if data were not normal the 
Mann-Whitney Rank Sum test was used to compare the data (JMP10, 
SAS).
Results
Progesterone inhibits ouabain binding to purified Na/K-
ATPase
Using purified Na/K-ATPase from porcine kidney medulla, we 
examined the ability of progesterone to compete for binding with 
3H-ouabain. Labeled ouabain was used due to the lack of availability 
of radiolabeled MBG. As shown in figure 1, pre-incubation of 
progesterone (100 µmol/L or 1 mmol/L) with purified Na/K-ATPase 
for 30 min before adding 3H-ouabain shifted the ouabain binding 
curve and increased the Kd of 3H-ouabain binding. These results are 
consistent with previous reports that progesterone may compete with 
ouabain binding to Na/K-ATPase [8,13]. Utilization of estradiol over 
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a wide range of concentrations in these studies did not appear to 
influence ouabain binding (data not shown).
Progesterone ameliorates MBG induced cardiac fibroblast 
collagen synthesis in vitro
To evaluate whether progesterone ameliorates the generation of 
fibrosis by competing with cardiotonic steroids for binding to Na/K-
ATPase, we examined collagen expression in cardiac fibroblasts treated 
with MBG alone or in combination with progesterone. Our data 
demonstrated that collagen protein level was significantly increased by 
more than two fold when cells were incubated for 24 h with either 1 nM 
or 100 nM MBG. Conversely, 100 nM progesterone was without effect 
on collagen synthesis (Figure 2). However, combination of MBG at a 
concentration of either, 1 nM or 100 nM with 100 nM progesterone 
shows a partial blocking effect of progesterone on MBG-induced 
collagen synthesis in adult rat cardiac fibroblasts.
Physiological differences between male and female CKD
To determine whether progesterone was capable of limiting cardiac 
hypertrophy and fibrosis induced by PNx, we performed PNx surgeries 
on male and female rats and monitored physiological measures 
throughout and at the end of the 3 week course of the experiment. 
The data shown in figure 3 indicate that PNx induces increased blood 
pressure in both male and female rats. However, the increase in blood 
pressure versus controls is significantly lower in female rats (165.0 ± 5.0 
vs. 200.0 ± 7.0 mmHg in male rats at the end of 3rd week).
An evaluation of cardiac hypertrophy after PNx in male and female 
rats, as measured by the ratio of heart weight in g (HW) to body weight 
in kg (BW) at the end of the 4th week following surgery, was carried 
out. As shown in figure 4, both male and female rats exhibit significant 
cardiac hypertrophy by 4 weeks after PNx surgery versus sham operated 
controls. There was no statistical difference in hypertrophy data from 
male versus female rats. Sirius Red staining as shown in figure 5, 
revealed significant increases in fibrosis in both male and female rats 
receiving PNx surgery compared to sham-operated controls. Female 
rats showed a milder increase compared to male rats, but this mild 
difference is not statistically significant.
Since progesterone levels in female rats may fluctuate in a cyclic 
manner, we also measured the progesterone levels in PNx rats at the 
end of the 4th week using the plasma collected during the sacrificing 
process. The result revealed that progesterone levels are 10-fold higher 
in female rats subjected to PNx than male rats operated in a similar 
manner (Figure 6). However there was no significant difference in the 
level of progesterone in Sham or PNx operated female rats (Data not 
shown).
Discussion
Uremic cardiomyopathy is characterized by cardiac hypertrophy, 
diastolic dysfunction and cardiac fibrosis, both in clinical subjects as well 
as in our experimental rat model, viz., PNx [1,3,10,14]. In this setting 
diastolic dysfunction can be attributed to both, an active component 
which is related to downregulation of Sarco (Endo) plasmic reticulum 
Ca2+ dependent ATPase (SERCA) expression, and cardiac fibrosis [15-
17]. Clinically, uremic cardiomyopathy is the leading cause of death 
in patients with end stage renal disease, and even modest degrees of 
renal insufficiency are associated with increased risk of cardiovascular 
disease and death [1,18]. Although morbidity and mortality risk is 
increased in both male and female patients, it should be noted that 
mortality is somewhat lower in female subjects [5,8]. These findings as 
well as our work with isolated purified Na/K-ATPase binding served as 
the basis for our current study.
In this and other studies progesterone demonstrated competitive 
inhibition with radiolabeled ouabain binding to purified Na/K-ATPase 
and it attenuated MBG-induced stimulation of cardiac fibroblast 
collagen production [8,13]. In our experiments, we did find that PNx 
induced less degree of blood pressure increase in female rats than in 
male rats. Fibrosis in female rats tended to be lower in female rats than 
in male rats, though not significantly. However, based on our data, it 
is not clear whether these mild effects are sufficient to reduce long-
term mortality in the setting of uremic cardiomyopathy in females. 
While progesterone concentrations appeared to be significantly higher 
in female PNx rats than in male PNx rats, these concentrations were 
apparently insufficient to significantly prevent the cardiac fibrosis and 
hypertrophy observed in PNx operated animals. Several factors may 
Figure 1: Progesterone competition with 3H-ouabain binding to purified Na/K-ATPase. Na/K-ATPase was purified from medulla of porcine kidney. For 
3H-ouabain binding assay, 30 µg of aliquots of purified Na/K-ATPase were incubated with different concentrations of 3H labeled ouabain in 500 µl K+-free Krebs 
solution for 30 min. After washing away the free unbound ouabain on a 0.2 µm filter, bound 3H-ouabain was measured via scintillation counting. To measure effect of 
progesterone on ouabain binding, 100 μM (A) or 1 mM (B) progesterone was pre- incubated with purified Na/K-ATPase for 30 min before addition of 3H labeled ouabain.
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play a role in differences observed between in vitro and in vivo findings 
noted here. First, progesterone concentrations are either elevated 
in a manner which is too transient or insufficient to prevent CTS 
induced cardiac fibrosis observed with experimental renal failure. This 
is somewhat surprising given that progesterone appeared to prevent 
ouabain binding to a similar degree as that found with canrenone [4], 
in addition to the fact that progesterone levels were essentially 10-fold 
higher in females as compared to that observed in male rats but these 
elevations may prove not to be enough physiologically to elicit changes 
on the whole animal level. We emphasize that the binding inhibition 
observed here did appear to be competitive, and higher levels of 
circulating MBG might be expected to overwhelm protective effects 
Figure 2: Progesterone partially inhibits MBG-induced collagen-1 
synthesis. Cardiac fibroblasts isolated from male Sprague-Dawley rats were 
serum-depleted in DMEM with 1% FBS for 24 h and were then treated with 
MBG alone or in combination with 100nM progesterone for additional 24 h. Cell 
lysates were collected in RIPA buffer and probed for collagen-1 using Western 
Blot. Panel A shows a representative blot; Panel B shows the quantitative data 
from the mean ± SEM from 6 experiments indicates p<0.05 vs. control.
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Figure 3: Male and Female blood pressure responses to PNx compared 
with sham operated controls over the period of study. FS: female sham; 
MS: male sham; FP: female PNx; MP: male PNx. Values are means ± SEM of 
6 animals at each point. A, indicates P<0.05 vs. sham; B, indicates p<0.01 vs. 
sham; C, indicates p<0.05 female vs. male. 
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Figure 4: Quantified Organ Data from male and female rats. Quantified 
heart weights (A), body weights (B), and HW/BW ratios (C), 4 weeks after 
PNx surgery. Data are represented as the means ± SEM of 6 animals in each 
group. a, indicates P<0.05, female vs male; b, indicates P<0.05, PNx vs Sham. 
Figure 5: Fibrosis was induced by PNx surgery in male and female Rats. 
Left Panel, representative Sirius Red/Fast Green stained photomicrographs at 
20X magnification obtained from male and female rats subjected to sham and 
PNx surgeries. Right Panel shows computer aided quantification data of photo 
micrographs taken from 6 animals in each group. *indicates P<0.05 vs sham.
Figure 6: Effects of PNx on plasma Progesterone concentrations. Data 
shown are the mean ± SEM of the plasma progesterone concentration 
of female and male rats subjected to PNx surgeries as measured by a 
commercial ELISA. Values are representative of plasma concentrations of 6 
animals in each group.*indicates p<0.01vs male.
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elicited by progesterone. An additional possibility exists that other sex 
hormones (e.g. estradiol) which were not studied in this setting in vivo 
had a profibrotic effect of their own [19-22]. The nature of the current 
study precluded the examination of these other hormones at this time.
In summation, although we were able to observe substantial 
Citation: Drummond CA, Buddny G, Haller ST, Liu J, Yan Y, et al. (2013) Gender differences in the development of uremic cardiomyopathy following 
partial nephrectomy: Role of progesterone. J Hypertens 2: 109. doi:10.4172/2167-1095.1000109
Page 5 of 5
Volume 2 • Issue 1 • 1000109
J Hypertens
ISSN: 2167-1095 JHOA an open access journal
interactions between progesterone and CTS, including MBG in our 
in vitro models, these compounds did not cause substantial gender 
based differences in physiological response to PNx surgery, a condition 
known to mimic uremic cardiomyopathy.
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